chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pain, Pyrexia
Clinical narrative: moderate body ache; Fever; chills; This is a spontaneous report from a contactable consumer.   This 52-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number not provided), on 03Apr2021 as single dose for COVID-19 immunization. No relevant medical history and concomitant medications were provided. The patient had received the first dose on 03Apr2021, and he had no symptoms at all for the past 3 weeks. He has as of this morning (Apr2021) some moderate body ache, fever and chills. He hasn't been sick in years. He is very diligent about keeping a mask on wherever he goes. He just wanted to get clearer when I was getting the vaccine administered that sometimes symptoms will show up a week to two weeks, but he couldn't recall if he said 3 weeks. The outcome of the events was unknown.   Information about lot/batch number has been requested.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm was sore; This is a spontaneous report from a contactable consumer (patient). A 67-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot Number: Unknown) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient had arm was sore on an unspecified date with outcome of unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever getting higher for the last two days; This is a spontaneous report from a contactable consumer (patient's mother) via medical information team. A 17-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection) via unspecified route of administration on 16Apr2021, as a single dose for COVID-19 immunisation. Medical history and Concomitant medication were not reported. Patient has had a fever for 6 days in 2021 with it getting higher for the last two days. She has been alternating Tylenol and Ibuprofen. Outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure increased, Dehydration
Clinical narrative: Blood pressure is elevated; dehydrated; This is a spontaneous report from a contactable consumer (patient) via Medical information team. A 70-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported), via an unspecified route of administration on 20Apr2021 at single dose for COVID-19 immunization. Medical history included slight chills on an unspecified date. The patient's concomitant medications were not reported. Patient did not have any symptoms on the date of vaccination and the next day too. Patient noticed his blood pressure was elevated on 22Apr2021 and asked if this was a normal symptom. He stated sometimes dehydration could cause an elevated blood pressure and said he might be dehydrated and asked if vaccine could cause this symptom. He reported that chills were not as bad and were a little less and went away and the vaccine must be helping with that. He asked if chills were normal before or after the vaccine. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash
Clinical narrative: rash on her legs and ankles; This is a spontaneous report from a contactable other healthcare professional (patient). A 30-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), via an unspecified route of administration on 18Apr2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced rash on her legs and ankles on 19Apr2021. The patient wants to know if it is ok to get the second dose after having this side effect. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Condition aggravated, Fatigue, Pain in extremity, Rash
Clinical narrative: rash on her legs and ankles; This is a spontaneous report from a contactable other healthcare professional (patient). A 30-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), via an unspecified route of administration on 18Apr2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced rash on her legs and ankles on 19Apr2021. The patient wants to know if it is ok to get the second dose after having this side effect. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Caller received the first Covid vaccine on 03Apr2021 and tested positive for the Covid virus a week later; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 03Apr2021 (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient reported that he received the first dose of Covid vaccine on 03Apr2021 and tested positive for the Covid virus a week later (Apr2021). He stated that he was out of isolation and has no symptoms. He asked if he should be able to receive the second dose on 24Apr2021. The patient underwent lab tests and procedures which included COVID-19: positive on Apr2021. The outcome of the event was unknown.  Information on the batch/lot number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: Swollen lymph node at the side where the shot was given. It is ''very swollen and tender, under the arm pit; swollen lymph node at the side where the shot was given. It is ''very swollen and tender, under the arm pit; This is a spontaneous report from a contactable consumer (patient) via Medical Information Team. A 64-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported), via an unspecified route of administration on Monday, 19Apr2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported) administered via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient had swollen lymph node at the side where the shot was given and it was very swollen and tender, under the arm pit. The patient asked how long this possible side effect would last and that whether she could use medication, put ice etc. The events were reported as non-serious. The outcome of the events was unknown.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Feeling abnormal, Headache, Malaise
Clinical narrative: she was "dead" "all day" / she could not even move; she was "dead" "all day" / she could not even move; her arm at the injection site was painful; headache; tired; muscle pain; chills; just "wasn't feeling great at all."; This is a spontaneous report from a contactable nurse (patient). A 37-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/Lot number was not reported), via an unspecified route of administration on 17Apr2021 at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient reported that she received her first dose of the Pfizer BioNTech COVID-19 vaccine on Saturday (17Apr2021) and experienced some side effects. She stated that on Saturday she felt fine, but on Sunday (18Apr2021), her arm at the injection site was painful. On Monday (19Apr2021), she was dead all day and reported that she could not even move. She also experienced headache, tired, muscle pain, chills, and just wasn't feeling great at all on an unspecified date in Apr2021. She stated that today she was feeling better. The outcome of the events was recovering.  Information on the batch/lot number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Movement disorder, Myalgia, Vaccination site pain
Clinical narrative: she was "dead" "all day" / she could not even move; she was "dead" "all day" / she could not even move; her arm at the injection site was painful; headache; tired; muscle pain; chills; just "wasn't feeling great at all."; This is a spontaneous report from a contactable nurse (patient). A 37-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/Lot number was not reported), via an unspecified route of administration on 17Apr2021 at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient reported that she received her first dose of the Pfizer BioNTech COVID-19 vaccine on Saturday (17Apr2021) and experienced some side effects. She stated that on Saturday she felt fine, but on Sunday (18Apr2021), her arm at the injection site was painful. On Monday (19Apr2021), she was dead all day and reported that she could not even move. She also experienced headache, tired, muscle pain, chills, and just wasn't feeling great at all on an unspecified date in Apr2021. She stated that today she was feeling better. The outcome of the events was recovering.  Information on the batch/lot number has been requested.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, Vaccination site pruritus
Clinical narrative: This is a spontaneous report from a contactable consumer (patient).  A 46-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number was not reported), via an unspecified route of administration on 21Apr2021 around 06:00 PM, at the age of 46-years-old, as SINGLEDOSE for covid-19 immunisation.  The patient received first dose of BNT162B2 on an unspecified date.  The patient medical history was not reported. The patient's concomitant medications were not reported.   The patient experienced injection site started to itch (vaccination site pruritus) (non-serious) on an unspecified date with outcome of unknown, fever of 101f (pyrexia) (non-serious) on an unspecified date with outcome of unknown.    Follow-up actions are closed. No need of further information
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Headache, Pyrexia, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: This is a spontaneous report from a contactable consumer (patient).  A 46-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number was not reported), via an unspecified route of administration on 21Apr2021 around 06:00 PM, at the age of 46-years-old, as SINGLEDOSE for covid-19 immunisation.  The patient received first dose of BNT162B2 on an unspecified date.  The patient medical history was not reported. The patient's concomitant medications were not reported.   The patient experienced injection site started to itch (vaccination site pruritus) (non-serious) on an unspecified date with outcome of unknown, fever of 101f (pyrexia) (non-serious) on an unspecified date with outcome of unknown.    Follow-up actions are closed. No need of further information
Sex: F
Vaccine: COVID19
Symptoms: Herpes dermatitis, Oral herpes
Clinical narrative: a flare-up of cold sores; herpes skin flare-ups; This is a spontaneous report from a contactable consumer (patient). A 23-year-old female patient received second doe of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 10Feb2021 (Lot number was not reported) as SINGLE DOSE for COVID-19 immunization. Medical history included oral herpes from an unknown date (she had them in her childhood but none in like 10 years). The patient's concomitant medications were not reported. The patent previously received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 20Jan2021 (Lot number was not reported) as SINGLE DOSE for COVID-19 immunization. A couple of weeks after on an unspecified date of 2021, the patient experienced a flare-up of cold sores and/or herpes skin flare-ups. The patient said she had them in her childhood but none in like 10 years. As a corrective measure her doctor put her on Valtrex for 30 days. The patient also reported that she saw a few articles talking about the Pfizer vaccine being a possible trigger for that. She commented: ' I thought I saw a study in a publication, Herpes Zoster following BNT162B2 COVID vaccine'. The outcome was reported as unknown for the reported events.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Diarrhoea, Lethargy
Clinical narrative: diarrhea; lethargic; This is a spontaneous report from a contactable pharmacist. A patient of unspecified age and gender received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on 26Mar2021 as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date in Apr2021 the patient experienced diarrhea and lethargic. It was reported that second dose was scheduled on 22Apr2021 and patient has had diarrhea and been lethargic for three weeks at the time of reporting. The outcome of events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 78.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vaccination site bruising
Clinical narrative: Caller reports that her right arm is black and blue; This is a spontaneous report from a contactable consumer (patient herself). A 78-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, lot number and expiration date were unknown), via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications was not reported. Previously the patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunisation. The patient received the second dose of the Covid vaccine on Saturday. Her right arm was black and blue. When she received the first vaccine, she didnot feel anything. When the second vaccine was administered, it felt as they took a dart into her arm or punched her arm. She was unable to utilize her left arm, in which she was unsure if this could have occurred due to having the vaccine in the same arm both times. The outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 78.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash, Vaccination site discolouration
Clinical narrative: Caller reports that her right arm is black and blue; This is a spontaneous report from a contactable consumer (patient herself). A 78-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, lot number and expiration date were unknown), via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications was not reported. Previously the patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunisation. The patient received the second dose of the Covid vaccine on Saturday. Her right arm was black and blue. When she received the first vaccine, she didnot feel anything. When the second vaccine was administered, it felt as they took a dart into her arm or punched her arm. She was unable to utilize her left arm, in which she was unsure if this could have occurred due to having the vaccine in the same arm both times. The outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Rash macular, Urticaria
Clinical narrative: bumps under her skin/hives on the left arm, up and down not just around the injection site with red spots. Then there were some that developed on the right arm; red spots; This is a spontaneous report from a contactable consumer (Patient) via Medical Information Team. A 72-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, Lot# unknown), on 25Mar2021 and second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, Lot# unknown), on 15Apr2021, both via an unspecified route of administration as a single dose for COVID-19 immunization. On 19Apr2021 or 20Apr2021, patient developed bumps under her skin or hives on the left arm, up and down, not just around the injection site with red spots. There were some that developed on the right arm but not as much. Patient wanted to know whether these were the side effects of the vaccine. The outcome of the events was unknown.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Parosmia, Taste disorder
Clinical narrative: metallic smell in mouth and nose; a raw meat taste and smell; a raw meat taste and smell; This is a spontaneous report from a contactable consumer, the patient. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient believed they are having a side effect from the Pfizer covid vaccine; a raw meat taste and smell, a metallic smell in mouth and nose which has gotten progressively worse. It started Saturday at 1 o clock. Every time their nose drains it taste like raw meat down the back of their throat. The patient would like to know how long their side effects from the covid vaccine would last. The outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Allergy to animal
Clinical narrative: he's developing a cat allergy; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration on 14Apr2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient stated that in his life he had never developed any allergies, he works in a house where they have a couple of cats, he was always surrounded by animals but has never had any allergy. Since Monday (on 19Apr2021) when he started working there, he has been feeling like he was developing a cat allergy or who knows to what, but he has never experienced allergy symptoms before, did the vaccine wake up an allergy gene. The patient was considering not getting the second dose. The outcome of the event was unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Broke out in hives; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received unknown dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Lot number was not reported) as SINGLE DOSE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported.  The patient reported that she broke out in hives on an unspecified date and asked whether this was side effect. The outcome was unknown for the reported event.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling, Pruritus
Clinical narrative: Her arm is very painful and swollen and very itchy; Her arm is very painful and swollen and very itchy; Her arm is very painful and swollen and very itchy; This is a spontaneous report from a contactable consumer (patient's daughter). A female patient (reporter's mother) of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported), via an unspecified route of administration on 20Apr2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's arm was very painful and swollen and very itchy on Apr2021. The reporter was wondering if she should be concerned and the patient wants to know why she had these side effects. The reporter asked that how long her mother should wait after her second dose to get the full efficacy of the vaccine. The outcome of the events was unknown at the reporting time.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Lethargy
Clinical narrative: Super tired and lethargic; Super tired and lethargic; This is a spontaneous report from a Pfizer sponsored program  from a non-contactable consumer. A 48-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 2 via an unspecified route of administration on an unspecified date (Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient previously took the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) on an unspecified date for covid-19 immunisation. The patient vaccine # 2 and she is experiencing every single side effect. She thought that she'd have felt better by now but super tired and lethargic. The outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Nasopharyngitis
Clinical narrative: fatigue; head cold; head ache; light headedness; This is a spontaneous report from a contactable physician. An 87-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration on 14Feb2021 as single dose for covid-19 immunisation. Medical history included ongoing diabetes Type2, ongoing chronic obstructive pulmonary disease (COPD), ongoing neuropathy peripheral, ongoing heart attack, ongoing blood pressure control, ongoing hyperlipidemia. Concomitant medications included all ongoing metformin; metoprolol; pravastatin; gabapentin; asa; vitamins nos (MULTIVITAMINUM). The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on 24Jan2021 for COVID-19 Immunization. There is no prior vaccination. He did report that after the second dose (believe the second shot was 14Feb2021) and he had some head cold, fatigue, but no fever and had a dull headache and felt a light headedness he started at that time that this started 3 days after receiving vaccine (17Feb2021 or 18Feb2021). He took Tylenol which helped his symptoms. The patient stated that the light headedness he experienced did not keep him from doing his ADLS. The outcome of event lightheaded was resolved with in 2 days, the outcome of the other events was unknown.  No follow up attempts are possible; Information about lot/batch number cannot be obtained.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm was hurting; This is a spontaneous report from a contactable consumer via Medical information team. A 76-year-old female consumer (patient) reported that she received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, Lot number and expiration date: Not reported) via an unspecified route of administration as a single dose for COVID-19 immunization on an unknown date. The patient past medical history included Alzheimer's. Concomitant medications were not reported. The patient reported that on an unknown date, she woke up in morning and her arm was hurting, so she felt her arm and the band aid felt wet. She wants to know if this could be fluid from the vaccine that leaked out. The outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: she got the first dose of the pfizer covid vaccine on 05Apr2021 and a few days later she had covid 19, like 6-7 days after; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 05Apr2021 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunization. The patient's medical history and concomitant medications were not reported.  The patient stated that she got the first dose of the pfizer covid vaccine on 05Apr2021 and a few days later she had covid 19, like 6-7 days after(Apr2021). The outcome of event was unknown.  Information on the lot/batch number has been requested.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Gout
Clinical narrative: Gout attack; This is a spontaneous report from a contactable consumer (patient's wife) via a medical information team. A 63-year-old male patient (reporter's husband) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), via an unspecified route of administration on an unspecified date (at the age of 63-year-old) as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that, caller and her husband was scheduled to receive the second dose this afternoon. Caller states that her husband had a gout attack this morning in which he took his treatment medication of Colcrys and Allopurinol. Caller states that he probably should not have taken the medication this morning and asked if these medications are going to interact with the vaccine or not. Referred to healthcare professional. Caller asked if her husband was able to take the vaccine at a later time or not. The outcome of the event was unknown.  No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Cystitis
Clinical narrative: This is a spontaneous report from a contactable consumer (patient) via the Pfizer sponsored program COVAX US support. A male patient of an unspecified age received the first dose of bnt162b2 via an unspecified route of administration on 31Mar2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient had his first dose of the covid-19 vaccine on 31Mar2021 and since then (2021) has been taking Nitrofurantoin 100mg for a bladder infection. The outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Muscle spasms, Vomiting
Clinical narrative: Cramps; vomiting; don't feel well; This is a spontaneous report from a contactable consumer (patient) via Medical information team. A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported), via an unspecified route of administration on 20Apr2021 on Tuesday at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the first dose and afterwards has experienced cramps, vomiting and not feeling well in Apr2021. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: HIV test, HIV test false positive
Clinical narrative: she is HIV positive, but it's a false positive; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that a female patient of an unspecified age received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient previously received the first dose of BNT162B2 on an unspecified date for Covid-19 immunization. Patient got both doses of the Covid vaccine and after getting both doses she donated blood to the red cross three weeks later. She just got a letter stating that she was HIV positive, but it was a false positive and wanted to know if anyone else has reported this. Outcome of the event was unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Pain in jaw
Clinical narrative: pain in her jaw; numbness on her left face; This is a spontaneous report from a contactable consumer (patient) via Pfizer-sponsored program. A female patient of an unspecified age received the first dose of bnt162b2, via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient 2nd dose schedule on 21Apr2021. Patient asked if she could take the 2nd dose vaccine because she experienced a reaction after the 1st dose (pain in her jaw and numbness on her left face). The outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Nasopharyngitis, Pain, Rhinorrhoea
Clinical narrative: runny nose; body aches; feels very tired; cold; This is a spontaneous report from a contactable consumer (daughter of the patient) received via medical information team. An 82-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), via an unspecified route of administration on 10Apr2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced runny nose, body aches, feels very tired and cold a day ago to this report, on an unspecified date in Apr2021. The consumer would like to know whether these side effects are related to the COVID vaccine, whether she can give anything for cold and is there an interference with the vaccine. The outcome of the events was unknown.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Blood immunoglobulin M, Blood immunoglobulin M increased
Clinical narrative: high IGM; This is a spontaneous report from a Pfizer sponsored program. A contactable consumer (patient) reported that a female patient of an unspecified age received bnt162b2 (UNSPECIFIED TRADE NAME, Solution for injection), dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously received the first dose of bnt162b2 for covid-19 immunisation. It was reported that swap from FC first time caller was consumer and she had had both shots and had labs done and was told she had a high IGM and she was asking what that means. The outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Abnormal behaviour, Stress, Tinnitus
Clinical narrative: severe reaction of tinnitus in the ears; demeanor is changing; stressed out; This is a spontaneous report from a contactable consumer (patient mother). A 41-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot number and expiration date was not provided) via an unspecified route on an unspecified date (reported as two Saturdays ago) as a single dose for covid-19 immunisation. Medical history and concomitant medications were not reported. On an unspecified date, patient had severe reaction of tinnitus in the ears, demeanor was changing stated her life was going to crap in conjunction with the side effect and life issues. Patient life was better until she got the Pfizer shot, it is ruining and destroying patients life. Reporter stated that patient cannot live like this and looks beaten down and was stressed out. Reporter inquired that was there an avenue or category to put people into that, this vaccine was changing their life. Patient will not get the second dose. Outcome for the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cough, Hypersensitivity, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: he tested positive for Covid-19; he thought this could be an allergy; cough; This is a spontaneous report from a contactable consumer (patient). A 55-years-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration on 08Apr2021 (Batch/Lot number was not reported) as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient, his wife and son received the first dose of the vaccine on 08Apr2021. He started with symptoms last Friday (16Apr2021), with cough, he thought this could be an allergy. On Monday (19Apr2021), he tested positive for COVID-19. His wife and son tested positive for COVID-19 on Tuesday (20Apr2021), they are asymptomatic. Their second dose is scheduled on 29Apr2021, he would like to know if there's a time recommended for him/them to receive the second dose of the vaccine, because some people say seven days, others say 14 days and if someone is asymptomatic 10 days. The outcome of the events was unknown.   Information on the batch/lot number has been requested.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cough, Feeling abnormal, Pain in extremity, Rhinorrhoea, SARS-CoV-2 test
Clinical narrative: he tested positive for Covid-19; he thought this could be an allergy; cough; This is a spontaneous report from a contactable consumer (patient). A 55-years-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration on 08Apr2021 (Batch/Lot number was not reported) as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient, his wife and son received the first dose of the vaccine on 08Apr2021. He started with symptoms last Friday (16Apr2021), with cough, he thought this could be an allergy. On Monday (19Apr2021), he tested positive for COVID-19. His wife and son tested positive for COVID-19 on Tuesday (20Apr2021), they are asymptomatic. Their second dose is scheduled on 29Apr2021, he would like to know if there's a time recommended for him/them to receive the second dose of the vaccine, because some people say seven days, others say 14 days and if someone is asymptomatic 10 days. The outcome of the events was unknown.   Information on the batch/lot number has been requested.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Sinus congestion
Clinical narrative: he tested positive for Covid-19; he thought this could be an allergy; cough; This is a spontaneous report from a contactable consumer (patient). A 55-years-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration on 08Apr2021 (Batch/Lot number was not reported) as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient, his wife and son received the first dose of the vaccine on 08Apr2021. He started with symptoms last Friday (16Apr2021), with cough, he thought this could be an allergy. On Monday (19Apr2021), he tested positive for COVID-19. His wife and son tested positive for COVID-19 on Tuesday (20Apr2021), they are asymptomatic. Their second dose is scheduled on 29Apr2021, he would like to know if there's a time recommended for him/them to receive the second dose of the vaccine, because some people say seven days, others say 14 days and if someone is asymptomatic 10 days. The outcome of the events was unknown.   Information on the batch/lot number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Epistaxis
Clinical narrative: Bloody nose; This is a spontaneous report from a contactable consumer (patient) via Medical information team. A 49-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported), via an unspecified route of administration on 21Apr2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number and expiration date were not reported) via an unspecified route of administration on 31Mar2021 at single dose for COVID-19 immunization. The patient experienced bloody nose on 22Apr2021 in the morning in moderate amounts, but had lightened up throughout the day. The outcome of the event was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Bone pain, Chills, Oropharyngeal pain, Pain
Clinical narrative: chills; bones were sore; soreness; Sore throat; This is a spontaneous report from a contactable consumer or other non hcp. A 72-year-old female patient received bnt162b2 (Solution for injection), via an unspecified route of administration on an unspecified date as SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced chills, bones were sore, soreness, sore throat on an unspecified date. Patient had chills soreness and bones were sore, that went away after she took Tylenol. She noticed a slight sore throat and she did not see that on the list of side effects on the paper she was given. Patient asked that "Is sore throat one of the side effects of thehe vaccine?". Therapeutic measures were taken as a result of chills, bones were sore (bone pain), soreness (pain), sore throat (oropharyngeal pain). Outcome of the event Sore throat was unknown and other events were recovered.  No follow-up attempts are needed; Information related to batch/Lot number could not be requested.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: On 07Apr2021, he tested positive for Covid; This is a spontaneous report from a contactable consumer (patient). A 47-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), first dose via an unspecified route of administration on 02Apr2021 (batch/lot number was not reported) as a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient received his first Pfizer Covid vaccine dose on 02Apr2021. On 07Apr2021, he tested positive for Covid. He stated that this past week he has started to feel better. He wanted to know if he can get the second dose tomorrow 23Apr2021 or should he wait. The case was assessed as non-serious. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness
Clinical narrative: stiff neck; This is a spontaneous report from a contactable consumer (patient reported herself). A 54-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot number: unknown), dose 2 via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. patient had side effect of a stiff neck since 27Mar2021 and has been using a moist heating pad and a hot tub to manage her stiff neck. The outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Nausea, Pain, Swelling, Vaccination site pain
Clinical narrative: Really achy; her armpit in the same armpit is super swollen; nauseous; Armpit sore; Her arm where she had the shot is really sore; This is a spontaneous report from a contactable consumer (Patient herself). A 26-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number:EN5318, Batch number: Unknown. Expiration date:31May2021) via unspecified route of administration on an right arm on 21Apr2021 at SINGLE DOSE for COVID-19 Immunization. The patients medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EN5318 Batch number: Unknown. Expiration date:31May2021) via unspecified route of administration on an right arm on 01Apr2021 at SINGLE DOSE for COVID-19 Immunization. Patient had her second dose of the Covid vaccine yesterday at 10:00. This morning, she woke up and she was really achy. Her arm where she had the shot is really sore, as well as her armpit in the same arm is super swollen. She is really nauseous today. She is mostly concerned about how swollen her armpit Treatment: She took Tylenol. The outcome of the event Arm where she had the shot is really sore was not recovered and outcome of all other events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Menstrual disorder, Oligomenorrhoea
Clinical narrative: It's like off and on bleeding; I had horrible stomach aches and cramps; I had horrible stomach aches and cramps; I watch my periods. It was suppose to start by the 10Apr2021. It never came but my body was acting as if I was on it./Everyday I was thinking it was going to start. It didn't start until the 21Apr2021; This is a spontaneous report from a contactable consumer.  A 51-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered on left arm on 11Mar2021 19:00 (Batch/Lot Number: EP6955) as single dose (at the age of 50 years old) for COVID-19 immunisation.  Medical history included breast cancer, asthma and known allergies: Nickel. There were no concomitant medications.  The patient stated, "I'm a breast cancer survivor so I watch my periods. It was suppose to start by the 10Apr2021. It never came but my body was acting as if I was on it. I had horrible stomach aches and cramps. Everyday I was thinking it was going to start. It didn't start until the 21Apr2021. And since being on it has been right! It's like off and on bleeding. I was starting to think something could be wrong but it dawned on me that I had my second Covid vaccine" on 12Apr2021.  The patient received no treatment. The outcome of the events was recovering.
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal discomfort, Paraesthesia, Pharyngeal swelling
Clinical narrative: throat swole but didn't close, was uncomfortable; throat swole but didn't close, was uncomfortable; face got tingling; This is a spontaneous report from a contactable consumer, the patient. A male patient of an unspecified age received first dose of bnt162b2 (Solution for injection), via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. Medical history included hypersensitivity (He has a lot of environmental and food allergies), food allergy. The patient's concomitant medications were not reported. On an unspecified date, the patient experienced throat swole but didn't close, was uncomfortable, face got tingling. The caller took the covid vaccine on Friday and had an immediate reaction; throat swole but didn't close, was uncomfortable, face got tingling. He has a lot of environmental and food allergies and knew he was having a reaction. He rates it as a 3/10, it lasted 3 hours, it was tolerable. The patient did not receive any treatment for the events. The clinical outcomes of the throat swole but didn't close, was uncomfortable, face got tingling were unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: she broke out in a rash on the left side of her face; This is a spontaneous report from a contactable consumer (patient herself). A 53-year-old female patient received a first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Unknown, Lot Number: ER8731, Expiry date: 31Jul2021), via an unspecified route of administration on left arm, on 17Apr2021 at 9.30 as a 0.3 mL, single dose for COVID-19 immunization. Medical history and concomitant medications of the patient were not reported. On 18Apr2021 she broke out in a rash on the left side of her face. The patient stated on 17 APR 2021 at 09:30 received vaccine then 24 hours later, which was Sunday, she would say mid afternoon, she broke out in a rash on the left side of her face and she was placed on antibiotics to clear it up doxycycline, and she's going to take that for a couple more days, it seems like its helping. The outcome of the event was Unknown.   No follow-up attempts are needed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: This morning, he woke up very fatigued and tired.; This is a spontaneous report from a contactable consumer (Patients mother). A male patient of unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot/Batch number: Unknown, Expiry date: Unknown) via unspecified route of administration on 21Apr2021 at SINGLE DOSE for COVID-19 Immunization. The patients medical history and concomitant medications were not reported. The patient previously took first dose of BNT162B2 for COVID-19 immunization. The reporter stated in morning, he woke up very fatigued and tired. Reporter was wondering if he can take Tylenol. The outcome of the event was unknown.  No Follow-up attempts are needed. Information about lot/batch number cannot be obtained.